Proteomics Services Market worth $16.46 billion by 2030
The report "Proteomics Services Market by Service Type (Core Proteomics, Bioinformatics), Application (Clinical, Drug Discovery), End User (Biopharmaceuticals, Hospitals) - Global Forecast to 2030" is projected to grow from USD 8.06 billion in 2025 and to reach USD 16.46 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 13.4% during the forecast period. The proteomics services market is growing due to factors such as the increasing outsourcing of biopharmaceutical R&D activities and the expansion of clinical and translational research.
Browse 983 market data Tables and 57 Figures spread through 781 Pages and in-depth TOC on "Proteomics Services Market by Service Type (Core Proteomics, Bioinformatics), Application (Clinical, Drug Discovery), End User (Biopharmaceuticals, Hospitals) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/proteomics-services-market-62466188.html
Core proteomics services accounted for largest market share, by Service type, in 2024.
By service type, the market is divided into core proteomics services and bioinformatics services. In 2024, core proteomics services accounted for the largest share, driven by strong demand for outsourced expertise due to shortages of skilled professionals, high equipment costs, and rapid advances in mass spectrometry. Increased pharmaceutical collaborations, the growing burden of chronic diseases, and government funding further strengthen these services' position relative to bioinformatics offerings.
Drug discovery & development segment to be fastest-growing application in proteomics services during forecast period.
By application, the market is divided into clinical diagnostics, drug discovery & development, and other applications. The drug discovery & development segment is likely to be the fastest-growing application in the proteomics services market, driven by its extensive use in target identification, lead optimization, and biomarker validation for both biologics and small molecules. Biopharmaceutical companies are increasingly adopting high-throughput proteomics to support precision therapies, driving this segment's growth faster than that of clinical diagnostics applications as demand for immunotherapy and personalized medicine rises.
North America accounted for largest share of proteomics services market in 2024.
The proteomics services market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America maintains its prominent share in the proteomics services market owing to surging demand for personalized medicines, expanding biologics pipelines, NIH-funded research consortia, CRO outsourcing trends, and AI-enhanced multi-omics platforms that are accelerating biomarker discovery and clinical translation.
Key players in the proteomics services market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies (US), Revvity (US), Illumina (US), Eurofins Scientific (Luxembourg), Charles River Laboratories (US), and Protagene (Germany).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Proteomics Services Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
